Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice
暂无分享,去创建一个
R. Cox | F. Krammer | A. Huckriede | Fan Zhou | M. Beukema | J. De Vries-Idema | Shuran Gong | Kasem Al-Jaawni
[1] J. C. Love,et al. Low protease activity in B cell follicles promotes retention of intact antigens after immunization , 2023, Science.
[2] P. Bieniasz,et al. Molecular fate-mapping of serum antibody responses to repeat immunization , 2023, Nature.
[3] D. van Baarle,et al. A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets , 2022, bioRxiv.
[4] S. Sambhara,et al. Progress towards the Development of a Universal Influenza Vaccine , 2022, Viruses.
[5] M. Meyer-Hermann,et al. Investigating the Mechanism of Germinal Center Shutdown , 2022, Frontiers in Immunology.
[6] Eric A. Appel,et al. Sustained delivery approaches to improving adaptive immune responses. , 2022, Advanced drug delivery reviews.
[7] E. Zoetendal,et al. The level and distribution of methyl-esters influence the impact of pectin on intestinal T cells, microbiota, and Ahr activation. , 2022, Carbohydrate polymers.
[8] Jordan A. Stinson,et al. Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles. , 2021, Vaccine.
[9] Eric A. Appel,et al. Modulation of injectable hydrogel properties for slow co‐delivery of influenza subunit vaccine components enhance the potency of humoral immunity , 2021, Journal of biomedical materials research. Part A.
[10] Eric A. Appel,et al. Prolonged Codelivery of Hemagglutinin and a TLR7/8 Agonist in a Supramolecular Polymer–Nanoparticle Hydrogel Enhances Potency and Breadth of Influenza Vaccination , 2021, ACS biomaterials science & engineering.
[11] D. Irvine,et al. Controlling timing and location in vaccines , 2020, Advanced Drug Delivery Reviews.
[12] A. Huckriede,et al. Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement. , 2020, Vaccine.
[13] M. Prausnitz,et al. Extended delivery of vaccines to the skin improves immune responses , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[14] F. Krammer. The human antibody response to influenza A virus infection and vaccination , 2019, Nature Reviews Immunology.
[15] Daniel W. Kulp,et al. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance , 2018, Cell.
[16] W. Hinrichs,et al. Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge , 2018, Journal of Controlled Release.
[17] Gavin J. D. Smith,et al. Influenza , 2018, Nature Reviews Disease Primers.
[18] L. Boon,et al. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines , 2018, bioRxiv.
[19] Carrie Reed,et al. Seasonal Incidence of Symptomatic Influenza in the United States , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] David J. Topham,et al. Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies , 2018, Cell.
[21] David Putnam,et al. A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles. , 2017, Vaccine.
[22] A. Monto,et al. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] G. Victora,et al. Germinal Center B Cell Dynamics. , 2016, Immunity.
[24] R. Varadarajan,et al. Stalking influenza by vaccination with pre-fusion headless HA mini-stem , 2016, Scientific Reports.
[25] P. Palese,et al. Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo , 2014, Nature Medicine.
[26] Antoine M. van Oijen,et al. Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization , 2013, PloS one.
[27] P. Palese,et al. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. , 2013, Journal of visualized experiments : JoVE.
[28] J. Wilschut,et al. Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100 , 2012, PloS one.
[29] J. Wrammert,et al. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses , 2012, Proceedings of the National Academy of Sciences.
[30] W. Hinrichs,et al. Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization. , 2011, Vaccine.
[31] N. Petrovsky,et al. Induction of mucosal and systemic antibody and T-cell responses following prime–boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations , 2011, The Journal of general virology.
[32] M. Severa,et al. Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling , 2008, PLoS pathogens.
[33] J. Wilschut,et al. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection. , 2008, Vaccine.
[34] K. Murali‐Krishna,et al. CD8 T Cell Expansion and Memory Differentiation Are Facilitated by Simultaneous and Sustained Exposure to Antigenic and Inflammatory Milieu1 , 2008, The Journal of Immunology.
[35] K. Schwarz,et al. Long‐lived memory CD8+ T cells are programmed by prolonged antigen exposure and low levels of cellular activation , 2006, European journal of immunology.
[36] Deborah M. Brown,et al. Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation , 2005, The Journal of experimental medicine.
[37] R. Cox,et al. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice , 2005, Scandinavian journal of immunology.
[38] C. Benoist,et al. Antigen persistence is required throughout the expansion phase of a CD4+ T cell response , 2005, The Journal of experimental medicine.
[39] R. Cox,et al. Comparison of the humoral immune response to split and whole virus vaccines in mice , 2004 .
[40] T. Storni,et al. Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction , 2003, The Journal of Immunology.
[41] K. Toellner,et al. T Helper 1 (Th1) and Th2 Characteristics Start to Develop During T Cell Priming and Are Associated with an Immediate Ability to Induce Immunoglobulin Class Switching , 1998, The Journal of experimental medicine.